MeSH term | MeSH ID | Detail |
---|---|---|
Ileus | D045823 | 3 associated lipids |
Rectal Diseases | D012002 | 1 associated lipids |
Angiolymphoid Hyperplasia with Eosinophilia | D000796 | 1 associated lipids |
Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.
To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with tacrolimus
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Jungersted JM et al. | Effects of topical corticosteroid and tacrolimus on ceramides and irritancy to sodium lauryl sulphate in healthy skin. | 2011 | Acta Derm. Venereol. | pmid:21365172 |
Laeijendecker R et al. | A comparison of treatment of oral lichen planus with topical tacrolimus and triamcinolone acetonide ointment. | 2006 | Acta Derm. Venereol. | pmid:16710580 |
Zattra E et al. | Labial melanotic macule after application of topical tacrolimus: two case reports. | 2010 | Acta Derm. Venereol. | pmid:20814635 |
Hao D et al. | Lymphocytic infiltration of the eyelid: two cases responding to tacrolimus and topical glucocorticoid. | 2013 | Acta Derm. Venereol. | pmid:23423497 |
Reitamo S et al. | Long-term treatment with 0.1% tacrolimus ointment in adults with atopic dermatitis: results of a two-year, multicentre, non-comparative study. | 2007 | Acta Derm. Venereol. | pmid:17721647 |
Seo SR et al. | Disrupted Skin Barrier is Associated with Burning Sensation after Topical Tacrolimus Application in Atopic Dermatitis. | 2017 | Acta Derm. Venereol. | pmid:28512670 |
Mandelin J et al. | One-year treatment with 0.1% tacrolimus ointment versus a corticosteroid regimen in adults with moderate to severe atopic dermatitis: A randomized, double-blind, comparative trial. | 2010 | Acta Derm. Venereol. | pmid:20169301 |
Ujiie H et al. | Successful treatment of nail lichen planus with topical tacrolimus. | 2010 | Acta Derm. Venereol. | pmid:20169322 |
Honda Y et al. | Disseminated Mycobacterium mantenii infection with multiple purulent cutaneous lesions. | 2015 | Acta Derm. Venereol. | pmid:25881714 |
Inoue T et al. | Prolonged topical application of tacrolimus inhibits immediate hypersensitivity reactions by reducing degranulation of mast cells. | 2006 | Acta Derm. Venereol. | pmid:16585982 |
Ortonne JP et al. | 0.3% Tacrolimus gel and 0.5% Tacrolimus cream show efficacy in mild to moderate plaque psoriasis: Results of a randomized, open-label, observer-blinded study. | 2006 | Acta Derm. Venereol. | pmid:16585986 |
Tzung TY et al. | Pimecrolimus and narrowband UVB as monotherapy or combination therapy in children and adolescents with atopic dermatitis. | 2006 | Acta Derm. Venereol. | pmid:16585987 |
Pitarch G et al. | Systemic absorption of topical tacrolimus in Pyoderma gangrenosum. | 2006 | Acta Derm. Venereol. | pmid:16585995 |
Hartmann A et al. | Occlusive treatment enhances efficacy of tacrolimus 0.1% ointment in adult patients with vitiligo: results of a placebo-controlled 12-month prospective study. | 2008 | Acta Derm. Venereol. | pmid:18779885 |
Yamamoto T and Nishioka K | Deep dermatophytosis during topical tacrolimus therapy for psoriasis. | 2003 | Acta Derm. Venereol. | pmid:12926803 |
Sand C | Topical tacrolimus ointment may induce skin tags in treated patients. | 2003 | Acta Derm. Venereol. | pmid:12926817 |
Park SW et al. | Topical tacrolimus (FK506): treatment failure in four cases of alopecia universalis. | 2002 | Acta Derm. Venereol. | pmid:12430746 |
Jedlicková H et al. | Granuloma faciale successfully treated with topical tacrolimus: a case report. | 2008 | Acta Dermatovenerol Alp Pannonica Adriat | pmid:18454269 |
Thaçi D and Salgo R | The topical calcineurin inhibitor pimecrolimus in atopic dermatitis: a safety update. | 2007 | Acta Dermatovenerol Alp Pannonica Adriat | pmid:17992459 |
Vukićević J et al. | Unilateral multiple lichen striatus treated with tacrolimus ointment: a case report. | 2009 | Acta Dermatovenerol Alp Pannonica Adriat | pmid:19350187 |